Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4H6Y2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.647 |
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.661 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.592 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.656 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.592 |
CLV_PCSK_PC7_1 | 137 | 143 | PF00082 | 0.655 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.664 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.616 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.669 |
DOC_CYCLIN_RxL_1 | 137 | 149 | PF00134 | 0.482 |
DOC_MAPK_gen_1 | 137 | 145 | PF00069 | 0.458 |
DOC_MAPK_gen_1 | 148 | 155 | PF00069 | 0.346 |
DOC_MAPK_gen_1 | 71 | 80 | PF00069 | 0.476 |
DOC_MAPK_gen_1 | 8 | 16 | PF00069 | 0.501 |
DOC_MAPK_MEF2A_6 | 113 | 120 | PF00069 | 0.430 |
DOC_MAPK_MEF2A_6 | 65 | 72 | PF00069 | 0.501 |
DOC_PP2B_LxvP_1 | 78 | 81 | PF13499 | 0.326 |
DOC_PP2B_PxIxI_1 | 88 | 94 | PF00149 | 0.448 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.373 |
LIG_14-3-3_CanoR_1 | 150 | 154 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 41 | 45 | PF00244 | 0.449 |
LIG_14-3-3_CanoR_1 | 74 | 78 | PF00244 | 0.353 |
LIG_14-3-3_CterR_2 | 163 | 166 | PF00244 | 0.369 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.415 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.454 |
LIG_FHA_2 | 100 | 106 | PF00498 | 0.405 |
LIG_LIR_Gen_1 | 43 | 51 | PF02991 | 0.428 |
LIG_LIR_Gen_1 | 76 | 85 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 50 | 54 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 76 | 80 | PF02991 | 0.409 |
LIG_SH2_CRK | 51 | 55 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.393 |
LIG_SUMO_SIM_par_1 | 89 | 94 | PF11976 | 0.464 |
LIG_TYR_ITIM | 75 | 80 | PF00017 | 0.461 |
MOD_CK1_1 | 18 | 24 | PF00069 | 0.378 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.430 |
MOD_CK2_1 | 130 | 136 | PF00069 | 0.510 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.363 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.378 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.471 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.420 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.413 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.255 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.445 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.349 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.453 |
MOD_PIKK_1 | 103 | 109 | PF00454 | 0.389 |
MOD_PIKK_1 | 122 | 128 | PF00454 | 0.499 |
MOD_PKA_2 | 149 | 155 | PF00069 | 0.458 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.418 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.444 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.451 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.453 |
MOD_Plk_2-3 | 149 | 155 | PF00069 | 0.341 |
MOD_Plk_2-3 | 73 | 79 | PF00069 | 0.402 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.420 |
MOD_Plk_4 | 19 | 25 | PF00069 | 0.389 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.423 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.421 |
MOD_SUMO_rev_2 | 146 | 153 | PF00179 | 0.448 |
TRG_DiLeu_BaEn_1 | 50 | 55 | PF01217 | 0.419 |
TRG_DiLeu_BaEn_4 | 156 | 162 | PF01217 | 0.340 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.379 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 139 | 142 | PF00400 | 0.464 |
TRG_ER_diArg_1 | 30 | 32 | PF00400 | 0.371 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.643 |
TRG_Pf-PMV_PEXEL_1 | 52 | 56 | PF00026 | 0.630 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PB87 | Leptomonas seymouri | 80% | 96% |
A0A0S4JEH6 | Bodo saltans | 49% | 100% |
A0A1X0NMA1 | Trypanosomatidae | 69% | 100% |
A0A3Q8I877 | Leishmania donovani | 86% | 100% |
C9ZHY9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 99% |
C9ZHZ0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
E9AGF6 | Leishmania infantum | 86% | 100% |
E9ANZ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4QGM4 | Leishmania major | 86% | 100% |